Market Overview:
The global copper tripeptide-1 market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing demand for anti-aging products and rising awareness about the benefits of copper tripeptide-1. Based on type, the global copper tripeptide-1 market has been segmented into 97% purity, 98% purity, and other. The 98% purity segment is expected to account for a major share of the global copper tripeptide-1 market in 2018. This can be attributed to its superior quality and high efficacy as compared to other types available in the market. Based on application, the global copper tripeptide-1 market has been segmented into cosmetics, pharmaceuticals, and other applications. The cosmetics segment is anticipated to hold a dominant position in terms of revenue contribution throughout the forecast period owing to an increase in demand for antiaging products across regions worldwide.
Product Definition:
Copper Tripeptide-1 is a peptide that has been found to have anti-inflammatory and antioxidant properties. It is believed to help improve the appearance of skin, hair, and nails.
97% Purity:
97% purity is a copper peptide-1, which is used as an ingredient in the formulation of skincare and haircare products. It helps in reducing wrinkles, improves skin hydration and elasticity, enhances skin color retention and evenness along with increasing cellular turnover rate. 97% purity has been reported to have excellent moisturizing properties for both skin types (oily & sensitive) without causing any irritation or allergic response.
98% Purity:
98% purity is a copper peptide-1 product, which is used as an ingredient in the manufacturing of Peptide-1. It helps to maintain the stability and efficacy of final products. 98% purity refers to concentration of final products that contains only 2% impurities or less than that according to USP General Chapter (97.8%) standards for pharmaceuticals ingredients.
Application Insights:
The cosmetics application segment led the global copper tripeptide-1 market in 2017 and is projected to witness significant growth over the forecast period. The product helps reduce skin irritation and has anti-inflammatory properties, which are likely to drive its demand in this segment. It also helps stimulate collagen production, minimize wrinkles, improve skin texture and tone as well as enhance hair growth. Copper peptides help protect the cornea of the eye from damage due to UV rays by strengthening its protective layer called ¢â‚¬Å“corneal endothelial barrier function¢â‚¬. This is expected to drive their demand in ophthalmic applications during future years.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. The presence of a large number of pharmaceutical companies in countries, such as China and India, has led to an increase in demand for copper peptides. In addition, increasing investments by major cosmetics manufacturers are anticipated to boost product demand over the next eight years.
The growth of end-use industries such as pharmaceuticals and cosmetics coupled with growing population is likely to be responsible for increased consumption levels across Asia Pacific region.
North America accounted for a significant share due to high research & development expenditure by pharmaceutical companies coupled with rising R&D initiatives undertaken by cosmetic manufacturers pertaining towards natural ingredients utilization methodsologies within their formulations.
Growth Factors:
- Increasing demand from the cosmetics industry for anti-aging products
- Rising awareness about the benefits of Copper Tripeptide-1 among consumers
- Growing number of research studies validating the efficacy of Copper Tripeptide-1 in skin care products
- Availability of a wide range of Copper Tripeptide-1 based skin care products in the market
- Entry of new players in the market
Scope Of The Report
Report Attributes
Report Details
Report Title
Copper Tripeptide-1 Market Research Report
By Type
97% Purity, 98% Purity, Other
By Application
Cosmetics, Pharmaceutical, Other
By Companies
Foshan Hytop New Material, A&PEP, CHEMLAND, Dermalab, Spec-Chem Industry, SMA Collaboratives
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Copper Tripeptide-1 Market Report Segments:
The global Copper Tripeptide-1 market is segmented on the basis of:
Types
97% Purity, 98% Purity, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cosmetics, Pharmaceutical, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Foshan Hytop New Material
- A&PEP
- CHEMLAND
- Dermalab
- Spec-Chem Industry
- SMA Collaboratives
Highlights of The Copper Tripeptide-1 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 97% Purity
- 98% Purity
- Other
- By Application:
- Cosmetics
- Pharmaceutical
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Copper Tripeptide-1 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Copper Tripeptide-1 is a peptide that is derived from copper and has therapeutic potential. Copper Tripeptide-1 has been shown to have anti-inflammatory properties, which may make it useful in treating conditions such as arthritis.
Some of the major companies in the copper tripeptide-1 market are Foshan Hytop New Material, A&PEP, CHEMLAND, Dermalab, Spec-Chem Industry, SMA Collaboratives.
The copper tripeptide-1 market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Copper Tripeptide-1 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Copper Tripeptide-1 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Copper Tripeptide-1 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Copper Tripeptide-1 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Copper Tripeptide-1 Market Size & Forecast, 2018-2028
4.5.1 Copper Tripeptide-1 Market Size and Y-o-Y Growth
4.5.2 Copper Tripeptide-1 Market Absolute $ Opportunity
Chapter 5 Global Copper Tripeptide-1 Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Copper Tripeptide-1 Market Size Forecast by Type
5.2.1 97% Purity
5.2.2 98% Purity
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Copper Tripeptide-1 Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Copper Tripeptide-1 Market Size Forecast by Applications
6.2.1 Cosmetics
6.2.2 Pharmaceutical
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Copper Tripeptide-1 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Copper Tripeptide-1 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Copper Tripeptide-1 Analysis and Forecast
9.1 Introduction
9.2 North America Copper Tripeptide-1 Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Copper Tripeptide-1 Market Size Forecast by Type
9.6.1 97% Purity
9.6.2 98% Purity
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Copper Tripeptide-1 Market Size Forecast by Applications
9.10.1 Cosmetics
9.10.2 Pharmaceutical
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Copper Tripeptide-1 Analysis and Forecast
10.1 Introduction
10.2 Europe Copper Tripeptide-1 Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Copper Tripeptide-1 Market Size Forecast by Type
10.6.1 97% Purity
10.6.2 98% Purity
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Copper Tripeptide-1 Market Size Forecast by Applications
10.10.1 Cosmetics
10.10.2 Pharmaceutical
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Copper Tripeptide-1 Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Copper Tripeptide-1 Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Copper Tripeptide-1 Market Size Forecast by Type
11.6.1 97% Purity
11.6.2 98% Purity
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Copper Tripeptide-1 Market Size Forecast by Applications
11.10.1 Cosmetics
11.10.2 Pharmaceutical
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Copper Tripeptide-1 Analysis and Forecast
12.1 Introduction
12.2 Latin America Copper Tripeptide-1 Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Copper Tripeptide-1 Market Size Forecast by Type
12.6.1 97% Purity
12.6.2 98% Purity
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Copper Tripeptide-1 Market Size Forecast by Applications
12.10.1 Cosmetics
12.10.2 Pharmaceutical
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Copper Tripeptide-1 Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Copper Tripeptide-1 Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Copper Tripeptide-1 Market Size Forecast by Type
13.6.1 97% Purity
13.6.2 98% Purity
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Copper Tripeptide-1 Market Size Forecast by Applications
13.10.1 Cosmetics
13.10.2 Pharmaceutical
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Copper Tripeptide-1 Market: Competitive Dashboard
14.2 Global Copper Tripeptide-1 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Foshan Hytop New Material
14.3.2 A&PEP
14.3.3 CHEMLAND
14.3.4 Dermalab
14.3.5 Spec-Chem Industry
14.3.6 SMA Collaboratives
